CoChat

Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats

Katsuki, Y, Takano, Y, Futamura, Y, Shibutani, Y, Aoki, D, Udagawa, Y, Nozawa, S · 1998 · European Journal of Endocrinology

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Dienogest, a synthetic steroid with progestational activity, is used as a component of oral contraceptives and is currently being evaluated clinically for the treatment of endometriosis. The present study was conducted to confirm the effects of dienogest on experimental endometriosis in rats and to elucidate its mechanism of action. DESIGN: Experimental endometriosis induced by autotransplantation of endometrium in rats. METHODS: Endometrial implants, immune system, and bone mineral were investigated after 3 weeks of medication. RESULTS: Dienogest (0.1-1 mg/kg per day, p.o.) reduced the endometrial implant volume to the same extent as danazol (100 mg/kg per day, p.o.). Simultaneously, dienogest ameliorated the endometrial implant-induced alterations of the immune system: i.e. it increased the natural killer activity of peritoneal fluid cells and splenic cells, decreased the number of peritoneal fluid cells, and decreased interleukin-1beta production by peritoneal macrophages. In contrast, danazol (100 mg/kg per day, p.o.) and buserelin (30 microg/kg per day, s.c.) had none of these immunologic effects. Additionally, combined administration of dienogest (0.1 mg/kg per day) plus buserelin (0.3 microg/kg per day) suppressed the bone mineral loss induced by buserelin alone, with no reduction of the effect on endometrial implants. In vitro studies on dienogest revealed an antiproliferative effect on rat endometrial cells due to inhibition of protein kinase C activity plus a partial progestational effect. CONCLUSIONS: Dienogest appears to be a potent agent with mechanisms of action different from those of danazol and GnRH agonists currently available for the treatment of endometriosis.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje.0.1380216

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 84

Metadata

Authors
Katsuki, Y., Takano, Y., Futamura, Y., Shibutani, Y., Aoki, D., Udagawa, Y., & Nozawa, S.
Affiliations
  • Mochida Pharmaceutical (Japan) (JP)
  • Keio University (JP)
Corresponding author
Katsuki, Y
Venue
European Journal of Endocrinology
Published
1998-02-01
Volume
138
Issue
2
Pages
216-226
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2115466905
Cited by
84
References
33
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 6 · 2014: 2 · 2013: 3 · 2012: 2
FWCI
2.25
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
dienogest, endometriosis, progestin therapy, endometriotic implants, danazol, buserelin, GnRH agonist, natural killer cells, IL-1β, peritoneal macrophages, bone mineral loss, protein kinase C, endometrial proliferation, immunomodulation
MeSH terms
Cyclic AMP, Animals, Buserelin, Cell Division, Cytotoxicity, Immunologic, Danazol, Disease Models, Animal, Endometriosis, Enzyme Inhibitors, Estradiol, Female, Immunity, Cellular, Interleukin-1, Killer Cells, Natural, Nandrolone, Progesterone, Protein Kinase C, Rats, Sprague-Dawley, Macrophages, Peritoneal, Cyclic AMP-Dependent Protein Kinases, Progesterone Congeners, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. https://app.cochat.ai/papers/10.1530/eje.0.1380216
The paper
Katsuki, Y., Takano, Y., Futamura, Y., Shibutani, Y., Aoki, D., Udagawa, Y., & Nozawa, S. (1998). Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1380216

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.